← Back to Analyst Consensus 
ALDX Buy
Aldeyra Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 2, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 30, 2026 | HC Wainwright & Co. | reiterate | Neutral → Neutral | — | 44% |
| Sep 29, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 18, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Nov 10, 2025 | BTIG | reiterate | Buy → Buy | $9 | 52% |
| May 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 7, 2025 | BTIG | maintain | Buy → Buy | $9 | 52% |
| Apr 4, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Mar 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Aug 2, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| May 6, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $10 | 52% |
| May 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $10 | 44% |
| Apr 3, 2024 | Oppenheimer | upgrade | Perform → Outperform | $10 | 52% |
| Oct 17, 2023 | Citigroup | maintain | Buy → Buy | $8 | 54% |
| Oct 17, 2023 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Aug 9, 2023 | Oppenheimer | reiterate | Outperform → Outperform | $14 | 52% |
| Jun 30, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 22, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 16, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 1, 2023 | Citigroup | maintain | Buy → Buy | $25 | 54% |
| May 5, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Mar 10, 2023 | Citigroup | maintain | Buy → Buy | $28 | 54% |
| Mar 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Mar 1, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Nov 21, 2022 | Citigroup | maintain | Buy → Buy | $23 | 54% |
| Jun 9, 2022 | Citigroup | maintain | — → Buy | $26 | 54% |
| Dec 21, 2021 | Citigroup | maintain | — → Buy | $21 | 54% |
| Dec 21, 2021 | SVB Leerink | maintain | — → Outperform | $15 | — |
| Apr 28, 2021 | Citigroup | maintain | Buy → Buy | $25 | 54% |
| Mar 12, 2021 | Citigroup | maintain | Buy → Buy | $22 | 54% |
| Mar 12, 2021 | SVB Leerink | initiate | — → Outperform | $22 | — |
| Feb 8, 2021 | HC Wainwright & Co. | initiate | — → Buy | $26 | 44% |
| Dec 16, 2020 | Berenberg | initiate | — → Buy | $32 | 29% |
| Oct 30, 2020 | Jefferies | initiate | — → Buy | $24 | 52% |
| Oct 16, 2020 | BTIG | initiate | — → Buy | $29 | 52% |
| Aug 11, 2020 | Citigroup | maintain | — → Buy | $22 | 54% |
| May 12, 2020 | Oppenheimer | initiate | — → Outperform | $12 | 52% |
| Dec 4, 2018 | Citigroup | initiate | — → Buy | $23 | 54% |
| Sep 26, 2018 | Stifel | maintain | Buy → Buy | $36 | 53% |
| Sep 13, 2018 | Janney Montgomery Scott | initiate | — → Buy | $0 | 55% |
| Jan 26, 2018 | Seaport Global | initiate | — → Buy | $13 | 51% |
| Oct 25, 2017 | Cantor Fitzgerald | initiate | — → Overweight | $22 | 50% |
| Sep 13, 2017 | Canaccord Genuity | maintain | — → Buy | $27 | 48% |
| Sep 26, 2016 | HC Wainwright & Co. | initiate | — → Buy | $18 | 44% |
| Jul 1, 2016 | Stifel | initiate | — → Buy | $0 | 53% |
| Sep 8, 2015 | Cowen & Co. | initiate | — → Outperform | $15 | — |
| Jul 1, 2015 | Canaccord Genuity | initiate | — → Buy | $16 | 48% |
| May 27, 2015 | Janney Montgomery Scott | initiate | — → Buy | $13 | 55% |
| Mar 25, 2015 | Chardan Capital | initiate | — → Buy | $16 | 47% |
| Jan 26, 2015 | Laidlaw & Co. | initiate | — → Buy | $30 | 20% |
Price Target Trend
Mar 31, 2026 Latest: $6.6 Oct 24, 2026
EPS Estimates
+1y $-0.28
Lo: $-0.40 Hi: $-0.16
4 analysts ▲1
0q $-0.09
Lo: $-0.11 Hi: $-0.08
4 analysts 0y $-0.34
Lo: $-0.39 Hi: $-0.31
4 analysts +1q $-0.10
Lo: $-0.13 Hi: $-0.08
4 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days